These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 6143835

  • 21. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
    Del Soldato P, Ghiorzi A, Cereda E, Donetti A.
    Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110
    [Abstract] [Full Text] [Related]

  • 22. Duodenal and gastric ulcer healing rates: a review.
    Legerton CW.
    Am J Med; 1984 Nov 19; 77(5B):2-7. PubMed ID: 6095656
    [Abstract] [Full Text] [Related]

  • 23. New drugs. H2 receptor antagonists--cimetidine and ranitidine.
    Feely J, Wormsley KG.
    Br Med J (Clin Res Ed); 1983 Feb 26; 286(6366):695-7. PubMed ID: 6130817
    [No Abstract] [Full Text] [Related]

  • 24. Cimetidine and ulcers.
    Br Med J; 1976 Nov 27; 2(6047):1275-6. PubMed ID: 11866
    [No Abstract] [Full Text] [Related]

  • 25. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP, Grebenev AL, Kkhorshed AM.
    Klin Med (Mosk); 1991 Mar 27; 69(3):27-34. PubMed ID: 1676773
    [No Abstract] [Full Text] [Related]

  • 26. [The medical therapy of peptic ulcer. The state of the art].
    Perroni GB, De Matteis G, Pellizzeri F, Cassone A, Malara F.
    Minerva Chir; 1992 Apr 15; 47(7):607-12. PubMed ID: 1350332
    [No Abstract] [Full Text] [Related]

  • 27. Response to "H2-receptor antagonists and duodenal ulcer recurrence".
    Kurata JH, Nogawa AN, Koch GG.
    Am J Gastroenterol; 1988 Dec 15; 83(12):1427-9. PubMed ID: 2904219
    [No Abstract] [Full Text] [Related]

  • 28. The assessment and management of peptic ulcer.
    Gibbs D.
    Br J Hosp Med; 1981 Mar 15; 25(3):278, 280, 282-3. PubMed ID: 6111368
    [No Abstract] [Full Text] [Related]

  • 29. Can the H2 receptor antagonists change the natural history of duodenal ulcer disease?
    Bardhan KD.
    Am J Gastroenterol; 1994 Jan 15; 89(1):3-6. PubMed ID: 7903845
    [No Abstract] [Full Text] [Related]

  • 30. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
    Gorshkov VA.
    Klin Med (Mosk); 2002 Jan 15; 80(9):66-70. PubMed ID: 12416232
    [No Abstract] [Full Text] [Related]

  • 31. [A new H2-receptor antagonist in the treatment of gastrointestinal diseases].
    Senfft U.
    Med Welt; 1982 Oct 29; 33(43):1516-8. PubMed ID: 6130463
    [No Abstract] [Full Text] [Related]

  • 32. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
    Lanas Arbeloa A, Serrano Aulló MT.
    Gastroenterol Hepatol; 1998 Jan 29; 21 Suppl 1():20-4. PubMed ID: 9549198
    [No Abstract] [Full Text] [Related]

  • 33. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G, De Natale F, Marino A.
    Clin Ter; 1989 Apr 15; 129(1):3-16. PubMed ID: 2567647
    [Abstract] [Full Text] [Related]

  • 34. [Changes in therapy of duodenal ulcers. The European Gastro-Club 1983 discusses new pathophysiologic and epidemiologic data referring to drug and surgical therapy].
    Demling L.
    Fortschr Med; 1983 Dec 15; 101(47-48):2195-6. PubMed ID: 6142849
    [No Abstract] [Full Text] [Related]

  • 35. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
    Ivashkin VT, Tkachenko EI, Grinevich VB, Sultanov VK, Inozemtsev SA.
    Ter Arkh; 1989 Dec 15; 61(8):59-62. PubMed ID: 2573963
    [Abstract] [Full Text] [Related]

  • 36. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology].
    Carella G.
    Clin Ter; 1984 Mar 31; 108(6):525-9. PubMed ID: 6144411
    [No Abstract] [Full Text] [Related]

  • 37. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T, Hirata W, Higichi S.
    Int J Clin Pharmacol Res; 2002 Mar 31; 22(2):29-35. PubMed ID: 12503773
    [Abstract] [Full Text] [Related]

  • 38. [Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems].
    Grigor'ev PIa, Isakov VA.
    Klin Med (Mosk); 1991 Oct 31; 69(10):93-7. PubMed ID: 1685004
    [No Abstract] [Full Text] [Related]

  • 39. Histamine H2-receptor antagonists.
    Feldman M, Richardson CT.
    Adv Intern Med; 1978 Oct 31; 23():1-24. PubMed ID: 24327
    [Abstract] [Full Text] [Related]

  • 40. [Anti-H2 and omeprazole in brief therapy of peptic ulcer].
    Piai G, Sabbatini F, Mazzacca G.
    Ann Ital Chir; 1990 Oct 31; 61(1):11-4. PubMed ID: 1978622
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.